Eastman Chemical Co. has performed better than its competitors in the trading days and has consistently soared in Q1. The shares' price target was lowered to $111.00 at Citigroup.
Institutional shareholders who own
86% of the company largely control it. This, however, broadens to 84% ownership, indicating stable backing. The company shared their First-Quarter 2024 Financial Results alongside announcing full-year 2023 financial results. Several analysts have studied their recommendations for Eastman Chemical. The company also reported solid cash flow amidst
macroeconomic challenges in 2023. Despite fluctuations in performance compared to competitors, Eastman Chemical has distinguished itself as a top dividend and value stock for the long term. In major strategic steps, Eastman Chemical plans to buy Commonwealth and has witnessed a rally of 18% in its shares over six months. Reflecting on its robust favorability, the stock was rated tactical outperform at Evercore ISI. In sustainability stride, Eastman unveiled
Naia Renew for Denim. Eastman's earnings and sales surpassed estimates in Q4, although it recently saw an EPS miss expectation in its Q1 2024 Earnings report.
Eastman Chemical Company EMN News Analytics from Tue, 05 Sep 2023 07:00:00 GMT to Sun, 30 Jun 2024 00:56:08 GMT -
Rating 4
- Innovation 3
- Information 7
- Rumor 2
